Generation and optimization of the self‐administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease. Issue 10 (28th April 2017)

• Record Type: Journal Article
• Authors: Casey, Lara J.; Tuttle, Angie; Grabell, Julie; Hopman, Wilma; Moorehead, Paul C.; Blanchette, Victor S.; Wu, John K.; Steele, MacGregor; Klaassen, Robert J.; Silva, Mariana; Rand, Margaret L.; James, Paula D.
• Is Part Of: Pediatric blood & cancer. Volume 64:Issue 10(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-04-28
• Subjects: bleeding assessment tools -- inherited bleeding disorders -- symptom assessment -- von Willebrand disease; Tumors in children -- Periodicals; Blood -- Diseases -- Periodicals; Cancer in children -- Periodicals; 618.92
• DOI: 10.1002/pbc.26588
• Languages: English
• ISSNs: 1545-5009

Abstract

Abstract: Objective: Our objective was to generate, optimize, and validate a self‐administered pediatric bleeding questionnaire (Self‐PBQ) as a screening tool for von Willebrand disease (VWD) in children referred to the hematology clinic for the first time. Study Design: The Self‐PBQ was generated by combining the validated expert‐administered PBQ and the International Society on Thrombosis and Hemostasis (ISTH) bleeding assessment tool (BAT). Medical terminology was translated into lay language requiring a grade 4 reading level. In Phase 1, the Self‐PBQ was optimized and the level of agreement between the Self‐PBQ and the expert‐administered PBQ was determined. Phase 2 established the normal range of bleeding scores (BSs) of the Self‐PBQ. Phase 3 examined the Self‐PBQ as a screening tool for first‐time referrals to the hematology clinic. Results: The Self‐PBQ is a reliable surrogate for the expert‐administered PBQ with an excellent intraclass correlation (ICC) of 0.917. The Self‐PBQ was scored with the PBQ and the ISTH‐BAT scoring systems, for which its normal BS ranges are –1 to 2 or 0 to 2, respectively. A positive Self‐PBQ BS (≥3) had a sensitivity of 78%, a specificity of 37%, a positive predictive value of 0.18, and a negative predictive value of 0.91 for identifying VWD in children being investigated by a hematologist for a bleeding disorder. Conclusion: The Self‐PBQ generates comparable BSs to the expert‐administered PBQ and is a reliable, reasonably sensitive screening tool to incorporate into the assessment of children presenting to a hematologist for the investigation of an inherited bleeding disorder.